Canada's Top 40 Research Hospitals: three years in the top 3!
Thanks to RI-MUHC researchers, trainees and staff, the MUHC maintains its leadership position in the Canadian research ecosystem
Vassilios Papadopoulos named Honorary Investigator at the RI-MUHC
Former executive director of the RI-MUHC leaves an enduring legacy
Alveolar macrophages on patrol for respiratory health
In a study published in Nature, RI-MUHC researchers examine how the lung copes with invading microbes
John Bergeron named to Order of Canada
The RI-MUHC researcher is recognized for excellence in the field of proteomics
MI4 announces redefined scope: How microbes shape human health and disease, from molecules to patients to populations
Five years in, the McGill Interdisciplinary Initiative in Infection and Immunity...
Breakthrough discovery on drug resistance named one of Quebec Science’s top Discoveries of the Year
A team of Montreal researchers discovers a new mechanism...
Former RI-MUHC trainee wins L’Oréal-Unesco science award
Omani researcher Maha al-Riyami, PhD, studies underlying causes of type 1 diabetes and other autoimmune diseases
Researchers discover how brain cells may be hardwired for vulnerability to deadly childhood brain tumour
A clearer understanding of how brain tumours originate during brain development is paving the way for improved therapies against pediatric high-grade gliomas, the leading cause of cancer-related deaths in children and young adults.
Happy first anniversary to the Quebec SmartCare Consortium!
Led by the Opal group at the RI-MUHC, the consortium has already made advances in data infrastructure and governance, as well as improving...
$2 million USD to investigate new approaches for prostate cancer treatment
RI-MUHC researcher David P. Labbé and a team of international collaborators will investigate the mechanisms...